LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE UTERINE CERVIX WITH C-ERBB-2, P53 ONCOPROTEIN EXPRESSION AND DNA QUANTIFICATION

被引：11
作者：
WALSH, CB
KAY, E
PRENDIVILLE, W
TURNER, M
LEADER, M
机构：
[1] Department of Pathology, Royal College of Surgeons in Ireland, Dublin, St Stephen's Green
来源：
HISTOPATHOLOGY | 1993年 / 23卷 / 06期
关键词：
LYMPHOEPITHELIOMA-LIKE CARCINOMA; ONCOPROTEINS; PLOIDY;
D O I：
10.1111/j.1365-2559.1993.tb01255.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：592 / 593
页数：2
相关论文
共 29 条
[21]   Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer [J].
Reinmuth, N ;
Brandt, B ;
Kunze, WP ;
Junker, K ;
Thomas, M ;
Achatzy, R ;
Scheld, HH ;
Semik, M .
EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) :991-996
[22]   Expression of CD30 (Ber-H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma-like carcinoma. A comparison study with anaplastic large cell lymphoma [J].
Kneile, J. R. ;
Tan, G. ;
Suster, S. ;
Wakely, P. E., Jr. .
HISTOPATHOLOGY, 2006, 48 (07) :855-861
[23]   Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes [J].
Leonardi, E ;
Cristofori, A ;
Caffo, O ;
DallaPalma, P .
ANALYTICAL CELLULAR PATHOLOGY, 1997, 15 (01) :31-45
[24]   RELATIONSHIP BETWEEN FLOW-CYTOMETRIC AND IMMUNOHISTOCHEMICALLY DETECTED C-ERBB-2 EXPRESSION, GRADE AND DNA-PLOIDY IN BREAST-CANCER [J].
BROTHERICK, I ;
SHENTON, BK ;
COWAN, WK ;
ANGUS, B ;
HORNE, CHW ;
HIGGS, MJ ;
LENNARD, TWJ .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (03) :137-145
[25]   DUCTAL CARCINOMA IRI SITU OF THE BREAST - A PROPOSAL FOR A NEW SIMPLIFIED HISTOLOGICAL CLASSIFICATION ASSOCIATION BETWEEN CELLULAR PROLIFERATION AND C-ERBB-2 PROTEIN EXPRESSION [J].
POLLER, DN ;
SILVERSTEIN, MJ ;
GALEA, M ;
LOCKER, AP ;
ELSTON, CW ;
BLAMEY, RW ;
ELLIS, IO .
MODERN PATHOLOGY, 1994, 7 (02) :257-262
[26]   Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: Potential tumor suppressor role for N-cadherin [J].
Zarka, TA ;
Han, AC ;
Edelson, MI ;
Rosenblum, NG .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) :240-243
[27]   Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression-a pilot study [J].
Zalata, Khaled Refaat ;
Elshal, Mohamed Farouk ;
Foda, Abd AlRahman Mohammad ;
Shoma, Ashraf .
TUMOR BIOLOGY, 2015, 36 (08) :6579-6584
[28]   Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb b-2 proteins on Reed-Sternberg cells: Prognostic significance in Hodgkin's disease [J].
Smolewski, P ;
Niewiadomska, H ;
Blonski, JZ ;
Robak, T ;
Krykowski, E .
NEOPLASMA, 1998, 45 (03) :140-147
[29]   ONCOPROTEINS AND TUMOR PROGRESSION IN PAPILLARY THYROID-CARCINOMA - PRESENCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2 PROTEIN, ESTROGEN-RECEPTOR RELATED PROTEIN, P21-RAS PROTEIN, AND PROLIFERATION INDICATORS IN RELATION TO TUMOR RECURRENCES AND PATIENT SURVIVAL [J].
AKSLEN, LA ;
VARHAUG, JE .
CANCER, 1995, 76 (09) :1643-1654
123